Visit CURE at and BioBus Educational Programs at

March 2008

Events Column
2/27  5:00 pm - 7:30 pm. MIT Enterprise Forum of CT. "Entrepreneurial Start Up: An innovative New Technology Mobile Business Intelligence Solution." Lawn Club, 193 Whitney Ave., New Haven, CT. more
3/6  3:30 pm - 6:00 pm. Connecticut Venture Group. "Investing in and Growing Consumer Product Companies". Panel discussions with reception to follow. Mariott Hotel, Stamford CT. more
3/19  3:00 pm - 6:00 pm. CURE and Yale OCR Present: Optherion. A BioHaven Entrepreneurship Seminar. Anlyan Center, Congress Avenue, New Haven, CT.  Reception and networking to follow. more
3/24  12:00 noon - 1:30 pm. UConn OTC Series. "DNA-Guided Medicine: Commercializing the New Biotechnology for Personalized Healthcare." Gualberto Ruaño, M.D., Ph.D. President and Chief Executive Officer, Genomas, Inc. Henry Low Center, UConn Health Center, Farmington, CT. more
3/25  4:30 pm - 7:30 pm. Connecticut Venture Group: International Trade Workshop. Bridgeport Holiday Inn, Bridgeport. more
3/26  Connecticut Innovations Annual Technology Celebration. The Aqua Turf Club, Southington, CT. more
4/11  8:00 am - 6:30 pm. Healthcare 2008 at the Yale School of Management. "Whose Healthcare is it Anyway? Understanding the Patient as a Consumer." Omni Hotel, New Haven, CT. more
4/16  3:30 pm - 6:00 pm. CURE and Yale OCR Present: The Next Big Idea - Creating a New Venture. A Special BioHaven Entrepreneurship Panel with Roger Longman of Windhover Publications. Reception and networking to follow. Anlyan Center, Congress Avenue, New Haven, CT. more
4/23  3:00 pm - 6:00 pm. CURE and Yale OCR Present: Vidus Ocular. A BioHaven Entrepreneurship Seminar. Anlyan Center, Congress Avenue, New Haven, CT.  Reception and networking to follow. more
Sector Vital But Needs to Gear for Uncertainty
From the desk of Paul Pescatello, President and CEO of CURE
One measure of the strength of Connecticut’s bioscience sector is its calendar of events. Every year brings numerous opportunities for CURE members and others to get together for face-to-face networking and the exchange of ideas in both formal and informal settings, and 2008 is no exception.
For the full story
Rib-X Tells the Story of Its Novel Antibiotics
Mix of science and business fuels attendance at CURE/Yale BioHaven Series
Rib-X Pharmaceuticals, Inc. is focused on the design and development of novel small-molecule antibiotics for the treatment of antibiotic-resistant infections. Detailing the company's story Feb 12 in New Haven, as part of the BioHaven seminar series presented by CURE and Yale OCR, were Bob Conerly, vice president and CFO, and Erin Duffy, Ph.D., vice president, structure based drug design. The team was introduced by Michelle Bowman of series sponsor PricewaterhouseCoopers.

For the full story
Pescatello Reports on UK Stem Cell Facilities
Last October, at the invitation of the UK government, a delegation from Connecticut toured a variety of stem cell research facilities in the UK. Paul Pescatello, a member of the delegation, reported January 15 to the Connecticut Stem Cell Advisory Committee.
For the full story
Two New Companies Join UConn's TIP
Two new companies, Revegen Corp and Escientia Life Sciences, will join UConn's Technology Incubation Program, which offers space and services to start-ups. UConn has additional wet lab openings in Farmington. "This is a great opportunity for early stage firms that want to leverage their resources through a relationship with the university," says Rita Zangari, Executive Program Director of the program.
For the full story
CURE Member News Digest
 454 Life Sciences announces new products and software Achillion names Olek chief medical officer
 Alexion acquires Oklahoma rights
 Applied Spine names Giordano chief medical officer
 Bayer HealthCare gets FDA approval for RECOTHROM™
 Boehringer Ingelheim completes RE-LY™ enrollment
 Bristol-Myers Squibb names West to board
 Carigent receives NSF grant
 Cognate takes Long Wharf space
 CuraGen names Cassidy CFO
 Danbury Hospital names Dodge for laboratory medicine
 GlaxoSmithKline reports results for Restless Legs drug
 Hartford Hospital establishes Gray Cancer Center
 HistoRx names Gupta CEO
 Ipsogen to provide products to AstraZeneca
 Johnson & Johnson CEO sees annual progress
 MannKind sees inhalable insulin progress
 NanoViricides reports it is on course
 Neurogen completes Phase I obesity study
 Pfizer CEO describes solid 2007
 PhRMA supports CEO Cancer Gold Standard™
 Purdue Pharma reports litigation victory
 Raindance invited to World Economic Forum
 Rib-X reports Phase II trials
 Vion confirms FDA go-ahead on  Cloretazine® trial
 Webster Bank names Klaus regional VP
 UConn researchers win equipment funding
 Yale bioengineers target brain tumors

For the full story
Copyright © 2008 Connecticut United for Research Excellence. All rights reserved.
Visit CURE at and BioBus Educational Programs at
Newsletter developed and edited by
HarveyMalis Communications LLC, Guilford, Conn.